Event Terms & Conditions

Registration Deadline

Registration closes on 31 September 2025, or as soon as 30 registrations are reached.

Message to display once registration closes/limit has been reached

General Restrictions

⦁ All registrations are limited to participants from the European Union (EU).
⦁ Payments must be made in EUR (€300 upfront payment per participant).
⦁ No multiple registrations per person (one registration per participant).

Cancellation Policy

  • Before 25 May 2025 (4 months before event): Full refund (€300 minus transaction fees).
  • 26 May – 31 July 2025 (4–8 weeks before event): 50% refund (€150 retained).
  • 1 August – 1 September 2025 (8–1 weeks before event): 25% refund, with a valid medical certificate / emergency presented (€225 retained).
  • From 2 September 2025 onwards (less than 4 weeks before event): No refund.
  • No-shows: No refund.
  • Cancellation Policy Link: https://docs.google.com/document/d/1l372Vuu0apo3CpHBe010N2Ql44ueHTawPpZ7awo-048/edit?usp=drive_link

Hotel Rooms

  • Hotel: Radisson Blu, Leipzig, Radisson Blu Hotel Leipzig
  • Augustusplatz 5-6, Leipzig, 04109, Germany
  • Room Nights Available:
    • 25 September 2025 (25 rooms)
    • 26 September 2025 (25 rooms)
  • The entire stay & registration is included in the €300 upfront payment
  • Room Booking

  • Cancellation Policy:
    • Until 25 May 2025: Full refund (€300, minus transaction fees).
    • Between 26 May – 31 July 2025: €150 refund (€150 retained to cover accommodation commitments).
    • Between 1 August – 1 September 2025: €75 refund (€225 retained to cover accommodation commitments).
    • From 2 September 2025 onwards: No refund (full amount retained).
    • No-shows: No refund will be granted.

Privacy & GDPR Compliance

close menu icon

Your Enquiries Are Welcome

We will respond to you by Email

""
 

Core-MD Project

Coordinating Research and Evidence for Medical Devices (CORE-MD)

New ways to test high-risk medical devices.

 

Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.


It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.

EAP Representative:

  • BERTHOLD KOLETZKO
Read more